These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3303448)
41. Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes. Pill J; Völkl A; Hartig F; Fahimi HD Arch Toxicol; 1992; 66(5):327-33. PubMed ID: 1610295 [TBL] [Abstract][Full Text] [Related]
42. Species differences in di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation. Lake BG; Gray TJ; Foster JR; Stubberfield CR; Gangolli SD Dev Toxicol Environ Sci; 1983; 11():595-8. PubMed ID: 6677511 [No Abstract] [Full Text] [Related]
43. Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys. Short RD; Robinson EC; Lington AW; Chin AE Toxicol Ind Health; 1987 Jun; 3(2):185-95. PubMed ID: 3617067 [TBL] [Abstract][Full Text] [Related]
44. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS; Cattley RC; Conway JG; Popp JA Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084 [TBL] [Abstract][Full Text] [Related]
45. Peroxisome induction studies on di(2-ethylhexyl)terephthalate. Topping DC; Ford GP; Evans JG; Lake BG; O'Donoghue JL; Lockhart HB Toxicol Ind Health; 1987 Jun; 3(2):63-78. PubMed ID: 3617070 [TBL] [Abstract][Full Text] [Related]
46. Interspecies differences in peroxisomes and peroxisome proliferation. Rodricks JV; Turnbull D Toxicol Ind Health; 1987 Jun; 3(2):197-212. PubMed ID: 3303448 [No Abstract] [Full Text] [Related]
48. Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate. Conway JG; Cattley RC; Popp JA; Butterworth BE Drug Metab Rev; 1989; 21(1):65-102. PubMed ID: 2696637 [No Abstract] [Full Text] [Related]
49. Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health. Reddy JK; Rao MS Arch Toxicol Suppl; 1987; 10():43-53. PubMed ID: 3555419 [TBL] [Abstract][Full Text] [Related]
51. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Reddy JK; Lalwai ND Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536 [TBL] [Abstract][Full Text] [Related]
52. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Huber WW; Grasl-Kraupp B; Schulte-Hermann R Crit Rev Toxicol; 1996 Jun; 26(4):365-481. PubMed ID: 8817083 [TBL] [Abstract][Full Text] [Related]
53. Phthalate esters, cystic kidney disease in animals and possible effects on human health: a review. Woodward KN Hum Exp Toxicol; 1990 Nov; 9(6):397-401. PubMed ID: 2271232 [TBL] [Abstract][Full Text] [Related]
54. Delineating peroxisome proliferator action to improve human risk assessment. Green S; Issemann I; Tugwood JD; Prince RA; Aldridge TC Prog Clin Biol Res; 1994; 387():311-33. PubMed ID: 7972256 [No Abstract] [Full Text] [Related]